We are monitoring the impact of COVID-19 & Recession alarm on MEA CRO Services Market Get in touch with us for detailed analysis Know More

Know More

Share on

Middle East and Africa Contract Research Organization (CRO) Services Market Research Report – Segmented By Type, Therapeutic Area, End User & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) – Industry Analysis on Size, Share, Trends, COVID-19 Impact and Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 6967
Pages: 145

MEA CRO Services Market Size (2022 to 2027)

During the forecast period, the size of the CRO services market in the Middle East and Africa is anticipated to grow at a 5.76% CAGR from 2022 to 2027, and it is estimated that the Middle-East and Africa market was valued at USD 1.83 billion in 2022 and is relied upon to achieve USD 2.42 billion by 2027.

Cybersecurity is becoming increasingly crucial from a business standpoint. Clinical trial sponsors are especially concerned about keeping their data secure, especially in light of a recent data breach involving clinical data. In addition, businesses are worried about what will happen if their data is stolen and how this will affect R&D. Pharmaceutical and biopharmaceutical companies have increased outsourcing of early-phase development services, clinical research, and laboratory testing services to boost profit margins, avoid high capital expenditure, and shorten drug development time, thereby propelling the Middle East and Africa market. As health institutions have discovered numerous benefits from traditional research organizations to commercial firms, demand for CROs has skyrocketed. As a result, investors have seen substantial growth prospects in CROs as demand for CROs has surged.

CROs are now broadening and extending their target market by offering services throughout the drug development life cycle. Increased technological investment and big data will play a key role across the Middle East and Africa. Most importantly, wearable devices, a potentially disruptive technology, present significant market opportunities, and CROs have recently begun to use data from mobile medical wearable devices to improve data quality and test efficiency, presenting lucrative opportunities for the contract research organization service market in the Middle East and Africa during the forecast period.

Regulatory pressure on CROs is increasing, which may stifle their market expansion. Furthermore, the market expansion would be hampered by reasons such as the difficulty in locating employees with specific project experience and the scarcity of highly skilled professionals. The market's growth is estimated to be significantly impacted by weak economies and restrictive government policies. Pharmaceutical and life science industries that rely on CROs to preserve their test data focus on new operating techniques. As previously said, the market's demand is gradually deteriorating. Outsourcing initiatives to international brand CRO firms has one major disadvantage: cost. This price includes the initial contract fee and the cost of any later changes to the service's content.

This research report on the MEA CRO services market has been segmented and sub-segmented into the following categories:

By Type:

  • Clinical Research Services         
  • Phase I Clinical Research Services        
  • Phase II Clinical Research Services       
  • Phase III Clinical Research Services      
  • Phase IV Clinical Research Services      
  • Early-Phase Development Services                
  • Discovery Studies       
  • Chemistry, Manufacturing, & Control (CMC)     
  • Preclinical Services      
    • Pharmacokinetics/Pharmacodynamics (PK/PD)
    • Toxicology Testing Services
    • Other Preclinical Services
  • Laboratory Services               
  • Bioanalytical Testing Services    
  • Analytical Testing Services       
    • Physical Characterization
    • Raw Material Testing
    • Batch-Release Testing
    • Stability Testing
    • Other Analytical Testing Services
  • Consulting Services         

By Therapeutic Area:

  • Oncology
  • CNS
  • Cardiovascular      

By End User:

  • Pharmaceutical
  • Biopharmaceutical
  • Medical Device Companies

By Country:

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Demand for CROs has seen significant growth in this region during recent times. Increased research and development of these services are key factors driving the Middle East and Africa CRO services market forward. The amount of research being done in this area is expanding due to government initiatives. Private firms have begun to spend more on these services due to their tremendous future potential. Clinical trials are becoming more common across the region, which has aided industry expansion tremendously. The market's progress has also been assisted by the incidence of chronic diseases resulting from population growth. Early-stage clinical trials are increasingly being outsourced to decrease expenses and increase revenue. In addition, companies attempt to avoid expensive costs by shortening the process and product validation time, accelerating market growth. These factors are predicted to drive the CRO services market in the Middle East and Africa during the forecasted period.

During the projected period, Saudi Arabia is expected to have the largest share of the Middle East and Africa CRO services market, followed by Africa. The growing number of investors interested in developing research advisory organizations is anticipated to open up many opportunities for contract research organization services to expand.

KEY MARKET PLAYERS:

The market is mainly dominated by companies such as Quintiles Transnational Holdings Inc., Laboratory Corporation of America Holdings, Pharmaceutical Product Development, PAREXEL International Corporation, ICON Plc, PRA Health Sciences Inc., InVentiv Health Inc., Charles River Laboratories International Inc., INC Research Holdings Inc., and Wuxi PharmaTech.

1.Introduction                                                  

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 Epidemology                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 Type                                              

                                5.1.1 Introduction                           

                                5.1.2 Clinical Research Services                 

                                                5.1.2.1 Phase I Clinical Research Services              

                                                5.1.2.2 Phase II Clinical Research Services             

                                                5.1.2.3 Phase III Clinical Research Services           

                                                5.1.2.4 Phase IV Clinical Research Services           

                                5.1.3 Early-Phase Development Services                              

                                                5.1.3.1 Discovery Studies             

                                                5.1.3.2 Chemistry, Manufacturing, & Control (CMC)        

                                                5.1.3.3 Preclinical Services           

                                                                5.1.3.3.1 Pharmacokinetics/Pharmacodynamics (PK/PD)

                                                                5.1.3.3.2 Toxicology Testing Services

                                                                5.1.3.3.3 Other Preclinical Services

                                5.1.4 Laboratory Services                             

                                                5.1.4.1 Bioanalytical Testing Services      

                                                5.1.4.2 Analytical Testing Services            

                                                                5.1.4.2.1 Physical Characterization

                                                                5.1.4.2.2 Raw Material Testing

                                                                5.1.4.2.3 Batch-Release Testing

                                                                5.1.4.2.4 Stability Testing

                                                                5.1.4.2.5 Other Analytical Testing Services

                                5.1.5 Consulting Services                             

                                5.1.6 Y-o-Y Growth Analysis, By Product                               

                                5.1.7  Market Attractiveness Analysis, By Product                            

                                5.1.8  Market Share Analysis, By Product                              

                5.2 Therapeutic Area                                     

                                5.2.1 Introduction                           

                                5.2.2 Oncology                 

                                5.2.3 CNS                            

                                5.2.4 Cardiovascular                       

                                5.2.5 Y-o-Y Growth Analysis, By Therapeutic Area                            

                                5.2.6 Market Attractiveness Analysis, By Therapeutic Area                          

                                5.2.7 Market Share Analysis, By Therapeutic Area                            

                5.3 End User                                      

                                5.3.1 Introduction                           

                                5.3.2 Pharmaceutical                     

                                5.3.3 Biopharmaceutical                               

                                5.3.4 Medical Device Companiest                            

                                5.3.5 Y-o-Y Growth Analysis, By End User                             

                                5.3.6  Market Attractiveness Analysis, By End User                          

                                5.3.7  Market Share Analysis, By End User                            

6. Geographical Analysis                                                              

                6.1 Introduction                                               

                                6.1.1 Regional Trends                    

                                6.1.2 Impact Analysis                     

                                6.1.3 Y-o-Y Growth Analysis                        

                                                6.1.3.1 By Geographical Area     

                                                6.1.3.2 By Therapeutic Area        

                                                6.1.3.3 By Type 

                                                6.1.3.4 By End User        

                                6.1.4  Market Attractiveness Analysis                     

                                                6.1.4.1 By Geographical Area     

                                                6.1.4.2 By Therapeutic Area        

                                                6.1.4.3 By End User        

                                                6.1.4.4 By Application    

                                6.1.5  Market Share Analysis                      

                                                6.1.5.1 By Geographical Area     

                                                6.1.5.2 By Therapeutic Area        

                                                6.1.5.3 By Type 

                                                6.1.5.4 By End User        

                6.2 Middle-East                                                

                6.3 Africa                                            

7.Strategic Analysis                                                        

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8.Market Leaders' Analysis                                                         

                8.1 Quintiles Transnational Holdings Inc.                                               

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Financial analysis                  

                                8.1.4 Recent Developments                       

                                8.1.5 SWOT analysis                       

                                8.1.6 Analyst View                          

                8.2 Laboratory Corporation of America Holdings                                               

                8.3 Pharmaceutical Product Development                                           

                8.4 PAREXEL International Corporation                                  

                8.5 ICON Plc                                       

                8.6 PRA Health Sciences Inc.                                       

                8.7 InVentiv Health Inc.                                

                8.8 Charles River Laboratories International Inc.                                

                8.9 INC Research Holdings Inc.                                  

                8.10 Wuxi PharmaTech.                                

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10.Market Outlook and Investment Opportunities                                                          

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  1. Middle East & Africa Contract Research Organization Services  Market By Type, From 2022 - 2027 (USD Billion)
  2. Middle East & Africa Preclinical Market By Region, From 2022 - 2027 (USD Billion)
  3. Middle East & Africa Clinical Research Market By Region, From 2022 - 2027 (USD Billion)
  4. Middle East & Africa Laboratory Market By Region, From 2022 - 2027 (USD Billion)
  5. Middle East & Africa Contract Research Organization Services  Market By Therapeutic Area, From 2022 - 2027 (USD Billion)
  6. Middle East & Africa Oncology Market By Region, From 2022 - 2027 (USD Billion)
  7. Middle East & Africa CNS Market By Region, From 2022 - 2027 (USD Billion)
  8. Middle East & Africa Cardiovascular Market By Region, From 2022 - 2027 (USD Billion)
  9. Middle East & Africa Contract Research Organization Services  Market By End User, From 2022 - 2027 (USD Billion)
  10. Middle East & Africa Pharmaceutical Market By Region, From 2022 - 2027 (USD Billion)
  11. Middle East & Africa Biopharmaceutical Market By Region, From 2022 - 2027 (USD Billion)
  12. Middle East & Africa Medical Device Companie Market By Region, From 2022 - 2027 (USD Billion)
  13. Middle East Contract Research Organization Services  Market By Type, From 2022 - 2027 (USD Billion)
  14. Middle East Contract Research Organization Services  Market By Therapeutic Area, From 2022 - 2027 (USD Billion)
  15. Middle East Contract Research Organization Services  Market By End User, From 2022 - 2027 (USD Billion)
  16. Africa Contract Research Organization Services  Market By Type, From 2022 - 2027 (USD Billion)
  17. Africa Contract Research Organization Services  Market By Therapeutic Area, From 2022 - 2027 (USD Billion)
  18. Africa Contract Research Organization Services  Market By End User, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

pdf
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample